2020/0128(COD)

Conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or prevent coronavirus disease

Basic information

2020/0128(COD)

COD - Ordinary legislative procedure (ex-codecision procedure)

Regulation

Subject

3.10.09.06 Agro-genetics, GMOs
4.20.02.06 Clinical practice and experiments
4.20.04 Pharmaceutical products and industry

Legislative priorities

The EU’s response to the Covid-19 pandemic

Status

Procedure completed

Key players

Key events

Date Event Reference Summary
17/06/2020 Legislative proposal published COM(2020)0261
19/06/2020 Committee referral announced in Parliament, 1st reading
10/07/2020 Decision by Parliament, 1st reading T9-0203/2020
15/07/2020 Act adopted by Council after Parliament's 1st reading
15/07/2020 Final act signed
15/07/2020 End of procedure in Parliament
17/07/2020 Final act published in Official Journal

Technical information

Procedure Information
Procedure reference 2020/0128(COD)
Procedure type COD - Ordinary legislative procedure (ex-codecision procedure)
Nature of procedure Legislation
Legislative instrument Regulation
Legal basis Rules of Procedure EP 170 Treaty on the Functioning of the EU TFEU 114-p1 Treaty on the Functioning of the EU TFEU 168-p4
Mandatory consultation of other institutions European Economic and Social Committee European Committee of the Regions
Stage reached in procedure Procedure completed
Committee dossier ENVI/9/03351

Documentation gateway

  • Document type Committee Reference Date Summary
    Text adopted by Parliament, 1st reading/single reading T9-0203/2020 10/07/2020
  • Document type Reference Date Summary
    Draft final act 00028/2020/LEX 15/07/2020
  • Document type Reference Date Summary
    Legislative proposal COM(2020)0261 17/06/2020
  • Document type Parliament/Chamber Reference Date Summary
    Contribution PT_PARLIAMENT COM(2020)0261 06/08/2020